PDCD1 and neoplasm: Similarly, Ricci et al. (2019) reported that methylation of the PDCD1 promoter in Merkel cell carcinoma is significantly associated with tumor aggressiveness and clinico-pathological parameters, reinforcing its potential relevance as a prognostic biomarker [34].